# The Impact of a Novel Infant Formula on Immunity, Gut Health and Growth

> **NCT06686433** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Biostime (Guangzhou) Health Products Limited** · enrollment: 342 (actual)

## Conditions studied

- Healthy Term Infant

## Interventions

- **OTHER:** Novel infant formula
- **OTHER:** Standard infant formula

## Key facts

- **NCT ID:** NCT06686433
- **Lead sponsor:** Biostime (Guangzhou) Health Products Limited
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-01-13
- **Primary completion:** 2026-08
- **Final completion:** 2026-12
- **Target enrollment:** 342 (ACTUAL)
- **Last updated:** 2026-03-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06686433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06686433, "The Impact of a Novel Infant Formula on Immunity, Gut Health and Growth". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06686433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*